Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400202 · ClinicalTrials.gov registry record
Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 44
- Enrollment target
NCT03400202 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 44 participants.
The verdict
NCT03400202 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study will evaluate the physiopathologic characteristics of dark circles in participants with various ethnicities and Fitzpatrick Skin Types and the impact of the dark circles on the quality of life.
Interventions
- DEVICE Skin imaging
- OTHER Facial cleanser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2018-11-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400202
The ClinicalTrials.gov registry entry for NCT03400202 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Skin imaging is the first listed.
NCT03400202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03400202 about?
NCT03400202 is a clinical study titled "Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles". This study will evaluate the physiopathologic characteristics of dark circles in participants with various ethnicities and Fitzpatrick Skin Types and the impact of the dark circles on the quality of life.
What is the current status of trial NCT03400202?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2018-02-02. Estimated completion is 2018-11-07.
What interventions are being tested in trial NCT03400202?
The interventions under investigation include: Skin imaging (DEVICE), Facial cleanser (OTHER).
Who is sponsoring clinical trial NCT03400202?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.